🇺🇸 FDA
Patent

US 9416165

Methods of inhibiting viral replication and improving T cell function employing soluble Tim-3 inhibitors

granted A61PA61P31/12A61P31/18

Quick answer

US patent 9416165 (Methods of inhibiting viral replication and improving T cell function employing soluble Tim-3 inhibitors) held by The Regents of the University of California expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P31/12, A61P31/18, A61P37/04, A61P43/00